You searched for "stapedius"

337 results found

Current management of unilateral sporadic vestibular schwannoma

Vestibular schwannoma is the commonest tumour of the cerebellopontine angle (80%) and accounts for around 8% of all intracranial tumours. The commonest primary presenting symptoms are audio vestibular. Hearing health professionals are often the first contact for patients with potential symptoms of vestibular schwannoma, with the majority then being seen and diagnosed by otorhinolaryngologists.

Adult speech testing in the UK

What do hearing healthcare providers see as the benefits and barriers to delivering speech testing? This article explores the latest research. Why speech testing? Speech tests have been used across ENT and audiology practice to measure an individual’s speech recognition...

The changing landscape for hearing loss therapeutics: novel advances of gene and cell therapies

Recent years have seen advances in hearing loss therapeutics, with novel treatments trialled in humans, and others nearing promising first-in-kind clinical trials. First successful clinical trials for a specific form of genetic hearing loss Very exciting news has emerged in...

Understanding the NAL-NL3 Prescription System: a new era of personalised hearing aid fitting

The NAL-NL3 system marks a transformative step in hearing aid fitting, shifting from a one-size-fits-most prescription to a modular, patient-centred approach. Developed by the National Acoustic Laboratories, this new system integrates a core audiogram-based prescription with targeted modules to address...

Empowering hearing rehabilitation professionals in Sub-Saharan Africa and Asia

The Hearing Healthcare Alliance empowers professionals across Africa and Asia through comprehensive training programmes, improving local hearing rehabilitation services. According to the World Health Organization (WHO), approximately 430 million people worldwide require rehabilitation for disabling hearing loss [1]. This number...

In conversation with Professor Graeme Clark

As we celebrate the cochlear implant, we celebrate an amazing work of innovative biomedical engineering that is a life-changer to many recipients around the world. We take for granted the arduous journey of the cochlear implant since its conception. Eric...

In conversation with Chrysa Spyridakou, Robert Nash, Emma Clement, Nish Mehta and Anne GM Schilder

Jaclyn Tan interviews members of the London-based multidisciplinary hearing team, about their insights to auditory neuropathy spectrum disorder, and their vision for the future management of this challenging range of conditions. Auditory neuropathy spectrum disorder (ANSD) describes a wide range...

In conversation with Prof Helge Rask-Andersen: on cell regeneration and treatment of human deafness

Helge Rask-Andersen, head of the inner ear research laboratory at the University of Uppsala in Sweden, has many achievements to his name. He was made an Honorary Member of ENT UK earlier this year. Gerry O’Donoghue caught up with him...

Jameel Muzaffar, Anne Schilder and James O’Hara

In a follow-up to the interview with Anne Schilder back in 2016*, Jameel Muzaffar speaks to Anne and to James O’Hara about the current research landscape in ENT in the UK. *Banerjee A. In conversation with Professor Anne Schilder. ENT...

Cancer genetics and signalling pathways in ENT – a review and discussion of how this can be applied to rare tumours

Introduction Cancer cases continue to increase worldwide, and­­ head and neck cancer is a major global health issue, with an estimated global burden of over 630,000 new cases and over 350,000 deaths per year [1]. The term ‘head and neck...

ENT and evidence-based medicine: How do they benefit each other?

How do we assess evidence, and how should ENT surgeons use EBM? Evidence-based medicine (EBM) is the practice of medicine based upon high quality scientific research. There are several formal definitions of EBM, the most widely quoted being that of...

Systemic agents in thyroid cancer

For those patients who have disseminated or unresectable thyroid cancer, Dr Arabella Hunt and Dr Kate Newbold review systemic treatments, their differences, toxicities and outcomes. Thyroid cancer is the most common endocrine malignancy. It is subdivided into differentiated (papillary, follicular...